Company Name: ProQR Therapeutics N.V.
ProQR Therapeutics N.V. is a biopharmaceutical company. The company is engaged in the development of RNA-based medicines for severe genetic disorders. The company’s lead product candidate is a therapy for cystic fibrosis.
Ticker Symbol: PRQR (NASDAQ)
Company Website: www.proqr.com
Social Media: ProQR Therapeutics LinkedIn
Headquarters: Leiden, The Netherlands